Johnson & Johnson

Artificial Intelligence

AI Drug Designer Isomorphic Details Lofty Plans for $2.1B in New Funding

Photo via Stephane Lemouton/SIPA/Newscom

Isomorphic previously raised $600 million in external funding last year, which was also led by NYC’s Thrive Capital.

1 min read

Photo by Marco Verch via CC BY 2.0

Healthcare

Pfizer Built a Covid Empire, But the World Has Moved On

Pfizer’s stock slumped its lowest level in more than 10 years. The world’s moved on from the pandemic, and nobody loves you when you’re down.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.